Redpoint Investment Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Redpoint Investment Management's DGX Position: Q3 2022 in Review
Redpoint Investment Management reduced its Quest Diagnostics (DGX) stake by 31% in Q3 2022, selling an estimated $211K and leaving 3,524 shares worth $432K. The position accounts for 0.06% of the portfolio, ranked #355.
Redpoint Investment Management first reported a position in DGX in Q4 2017 and has held it in 20 quarters since. The position peaked at $3.86M in Q1 2018. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.
- Redpoint Investment Management held 3,524 shares of Quest Diagnostics worth $432K as of Q3 2022.
- Redpoint Investment Management sold 1,603 Quest Diagnostics shares in Q3 2022, an estimated $211K.
- Quest Diagnostics made up 0.06% of Redpoint Investment Management's portfolio in Q3 2022, its #355 holding.
- Redpoint Investment Management first reported a position in Quest Diagnostics in Q4 2017 and has held it in 20 quarters since.
- Redpoint Investment Management's Quest Diagnostics position peaked at $3.86M in Q1 2018.
- 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.
Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.